estriol has been researched along with Urinary Tract Infections in 25 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In postmenopausal women, the combination of HA, CS, curcumin and quercetin per os was effective in preventing recurrent urinary tract infections, especially if administered with vaginal estrogen therapy." | 9.22 | Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. ( Colacurci, N; De Franciscis, P; Del Deo, F; Gallo, P; Grimaldi, A; Iervolino, SA; Pezzella, M; Rappa, C; Tammaro, C; Torella, M, 2016) |
| " acidophili, estriol plus pelvic floor rehabilitation was effective and should be considered as first-line treatment for symptoms of urogenital aging in postmenopausal women." | 9.19 | Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women. ( Capobianco, G; Cherchi, PL; Dessole, M; Dessole, S; Meloni, GB; Wenger, JM, 2014) |
| "Our results showed that combination therapy with estriol plus pelvic floor rehabilitation was effective and should be considered as a first-line treatment for symptoms of urogenital aging in postmenopausal women." | 9.16 | Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. ( Borghero, G; Capobianco, G; Cherchi, PL; Dessole, F; Dessole, S; Donolo, E, 2012) |
| "We enrolled 93 postmenopausal women with a history of recurrent urinary tract infections in a randomized, double-blind, placebo-controlled trial of a topically applied intravaginal estriol cream." | 9.07 | A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. ( Raz, R; Stamm, WE, 1993) |
| "A block randomized, double-blind, group-comparative, placebo-controlled study was conducted to assess the effect of oestriol on recurrent urinary tract infections in postmenopausal women." | 9.07 | Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. ( Andersen, P; Bodd, E; Gjersøe, E; Johannessen, GR; Johnsen, N; Kirkengen, AL, 1992) |
| " No significant differences in prophylactic antibiotic treatment with nitrofurantoin and norfloxacin, trimethoprim, sulfamethoxazole/trimethoprim, methamine hippurate, estriol, or cefaclor were found in clinical or microbiological cure in adult nonpregnant women with recurrent urinary tract infections (9 randomized control trials, 673 patients, relative risk ratio, 1." | 8.93 | Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis. ( Gregory, WT; Guran, LA; McDonagh, MS; Price, JR, 2016) |
| "In postmenopausal women, the combination of HA, CS, curcumin and quercetin per os was effective in preventing recurrent urinary tract infections, especially if administered with vaginal estrogen therapy." | 5.22 | Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women. ( Colacurci, N; De Franciscis, P; Del Deo, F; Gallo, P; Grimaldi, A; Iervolino, SA; Pezzella, M; Rappa, C; Tammaro, C; Torella, M, 2016) |
| " acidophili, estriol plus pelvic floor rehabilitation was effective and should be considered as first-line treatment for symptoms of urogenital aging in postmenopausal women." | 5.19 | Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women. ( Capobianco, G; Cherchi, PL; Dessole, M; Dessole, S; Meloni, GB; Wenger, JM, 2014) |
| "Our results showed that combination therapy with estriol plus pelvic floor rehabilitation was effective and should be considered as a first-line treatment for symptoms of urogenital aging in postmenopausal women." | 5.16 | Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. ( Borghero, G; Capobianco, G; Cherchi, PL; Dessole, F; Dessole, S; Donolo, E, 2012) |
| "To assess the efficacy of oral oestriol in the prevention of recurrent urinary tract infections in elderly women." | 5.08 | Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. ( Abbott, D; Benness, C; Cardozo, L, 1998) |
| "We enrolled 93 postmenopausal women with a history of recurrent urinary tract infections in a randomized, double-blind, placebo-controlled trial of a topically applied intravaginal estriol cream." | 5.07 | A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. ( Raz, R; Stamm, WE, 1993) |
| "A block randomized, double-blind, group-comparative, placebo-controlled study was conducted to assess the effect of oestriol on recurrent urinary tract infections in postmenopausal women." | 5.07 | Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. ( Andersen, P; Bodd, E; Gjersøe, E; Johannessen, GR; Johnsen, N; Kirkengen, AL, 1992) |
| " No significant differences in prophylactic antibiotic treatment with nitrofurantoin and norfloxacin, trimethoprim, sulfamethoxazole/trimethoprim, methamine hippurate, estriol, or cefaclor were found in clinical or microbiological cure in adult nonpregnant women with recurrent urinary tract infections (9 randomized control trials, 673 patients, relative risk ratio, 1." | 4.93 | Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis. ( Gregory, WT; Guran, LA; McDonagh, MS; Price, JR, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seaberg, P | 1 |
| Jadoon-Khamash, E | 1 |
| Vegunta, S | 1 |
| Capobianco, G | 2 |
| Wenger, JM | 1 |
| Meloni, GB | 1 |
| Dessole, M | 1 |
| Cherchi, PL | 2 |
| Dessole, S | 2 |
| Price, JR | 1 |
| Guran, LA | 1 |
| Gregory, WT | 1 |
| McDonagh, MS | 1 |
| Torella, M | 1 |
| Del Deo, F | 1 |
| Grimaldi, A | 1 |
| Iervolino, SA | 1 |
| Pezzella, M | 1 |
| Tammaro, C | 1 |
| Gallo, P | 1 |
| Rappa, C | 1 |
| De Franciscis, P | 1 |
| Colacurci, N | 1 |
| Brostrøm, S | 1 |
| Lose, G | 1 |
| Donolo, E | 1 |
| Borghero, G | 1 |
| Dessole, F | 1 |
| Raz, R | 2 |
| Colodner, R | 1 |
| Rohana, Y | 1 |
| Battino, S | 1 |
| Rottensterich, E | 1 |
| Wasser, I | 1 |
| Stamm, W | 1 |
| Hejlová, P | 1 |
| Zivný, J | 1 |
| Pinggera, GM | 1 |
| Feuchtner, G | 1 |
| Frauscher, F | 1 |
| Rehder, P | 1 |
| Strasser, H | 1 |
| Bartsch, G | 1 |
| Herwig, R | 1 |
| Calandra, C | 1 |
| Abell, DA | 1 |
| Beischer, NA | 3 |
| Stamm, WE | 1 |
| Svanborg, C | 1 |
| Molander, U | 1 |
| Cardozo, L | 1 |
| Benness, C | 1 |
| Abbott, D | 1 |
| Kivinen, S | 1 |
| Tuimala, R | 1 |
| Kirkengen, AL | 1 |
| Andersen, P | 1 |
| Gjersøe, E | 1 |
| Johannessen, GR | 1 |
| Johnsen, N | 1 |
| Bodd, E | 1 |
| Brandberg, A | 3 |
| Mellström, D | 3 |
| Persson, U | 1 |
| Odegaard, K | 1 |
| Samsioe, G | 2 |
| Bergström, H | 1 |
| Leroy, JL | 1 |
| May, JP | 1 |
| Codaccioni, X | 1 |
| Monnier, JC | 1 |
| Delecour, M | 1 |
| Carrington, ER | 1 |
| Oesterling, MJ | 1 |
| Adams, FM | 1 |
| Sele, V | 1 |
| Frandsen, VA | 1 |
| Bhargava, VL | 1 |
| Brown, JB | 2 |
| Smith, MA | 2 |
| Townsend, L | 1 |
| Holsman, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection (rUTI) in Post-menopausal Women: a Cross-over Randomized Controlled Trial[NCT05723601] | Phase 4 | 24 participants (Anticipated) | Interventional | 2024-01-31 | Not yet recruiting | ||
| Probiotics and the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)[NCT03250208] | 8 participants (Actual) | Interventional | 2017-09-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for estriol and Urinary Tract Infections
| Article | Year |
|---|---|
Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cefaclor; Estriol; Female; Humans; Nit | 2016 |
[Oestrogen for prevention of recurrent urinary tract infections in postmenopausal women--a survey of a Cochrane review].
Topics: Administration, Intravaginal; Anti-Infective Agents, Urinary; Estradiol; Estriol; Estrogens; Evidenc | 2009 |
8 trials available for estriol and Urinary Tract Infections
| Article | Year |
|---|---|
Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women.
Topics: Administration, Intravaginal; Aged; Aging; Atrophy; Combined Modality Therapy; Electric Stimulation | 2014 |
Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Topics: Aging; Anti-Infective Agents, Urinary; Antioxidants; Atrophic Vaginitis; Chondroitin Sulfates; Combi | 2016 |
Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.
Topics: Administration, Intravaginal; Aging; Analysis of Variance; Atrophy; Dyspareunia; Electric Stimulatio | 2012 |
Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Estriol; Female; Humans; Middle Aged; Nitro | 2003 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Topics: Administration, Intravaginal; Double-Blind Method; Enterobacteriaceae; Estriol; Female; Follow-Up St | 1993 |
Urinary incontinence and related urogenital symptoms in elderly women.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Cohort Studies; Contraceptives, Oral; Do | 1993 |
Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women.
Topics: Administration, Oral; Aged; Double-Blind Method; Estriol; Estrogen Replacement Therapy; Female; Huma | 1998 |
Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Estriol; Female; Humans; Hydrogen-Ion Concentration; M | 1992 |
15 other studies available for estriol and Urinary Tract Infections
| Article | Year |
|---|---|
Managing Recurrent Urinary Tract Infections in Postmenopausal Women.
Topics: Administration, Intravaginal; Aged, 80 and over; Estriol; Female; Humans; Postmenopause; Recurrence; | 2018 |
[Effect of vaginal estriol on urogenital symptoms in postmenopausal women].
Topics: Administration, Intravaginal; Aged; Estriol; Female; Humans; Middle Aged; Postmenopause; Recurrence; | 2004 |
Effects of local estrogen therapy on recurrent urinary tract infections in young females under oral contraceptives.
Topics: Administration, Intravaginal; Adolescent; Adult; Age Factors; Contraceptives, Oral; Estriol; Feasibi | 2005 |
Maternal obesity in pregnancy.
Topics: Apgar Score; Birth Weight; Breech Presentation; Delivery, Obstetric; Estriol; Female; Glucose Tolera | 1981 |
Resistance to urinary tract infection.
Topics: Bacterial Infections; Disease Susceptibility; Estriol; Female; Humans; Male; Recurrence; Sex Factors | 1993 |
[Decreased maternal urinary estriol due to methenamine hippurate administration during pregnancy].
Topics: Estriol; Female; Hippurates; Humans; Methenamine; Pregnancy; Pregnancy Complications, Infectious; Ur | 1977 |
[Increased use of estriol treatment of elderly women decreases the costs to society].
Topics: Aged; Estriol; Female; Humans; Quality of Life; Sweden; Urinary Incontinence; Urinary Tract Infectio | 1990 |
Low dose oral estriol treatment in elderly women with urogenital infections.
Topics: Administration, Oral; Aged; Aged, 80 and over; Estriol; Female; Genital Diseases, Female; Humans; La | 1987 |
Estriol in recurrent urinary tract infection in elderly women?
Topics: Aged; Aged, 80 and over; Estriol; Female; Humans; Male; Recurrence; Urinary Tract Infections | 1987 |
[Peroral estriol treatment of older women with urogenital infections].
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Estriol; Female; Humans; Urinary Tract | 1985 |
[Surveillance of the pregnant diabetic. A 12-year experience: 1962-1973 (201 cases)].
Topics: Amniotic Fluid; Apgar Score; Birth Weight; Estriol; Female; Fetal Death; Fetal Diseases; Fetal Heart | 1974 |
Renal clearance of estriol in complicated pregnancies.
Topics: Creatinine; Estriol; Female; Gestational Age; Humans; Hypertension; Kidney; Kidney Diseases; Placent | 1970 |
Drug-interference with oestriol estimations during pregnancy.
Topics: Anti-Infective Agents, Urinary; Estriol; Female; Glucuronidase; Methenamine; Pregnancy; Pregnancy Co | 1967 |
The incidence and significance of low oestriol excretion in an obstetric population.
Topics: Abortion, Threatened; Adult; Anemia; Australia; Birth Weight; Delivery, Obstetric; Embryonic and Fet | 1968 |
Urinary estriol excretion in pregnancy anemias.
Topics: Adult; Anemia; Birth Weight; Blood Transfusion; Eclampsia; Estriol; Female; Fetal Death; Hemoglobino | 1968 |